All Stories

  1. Attention deficit hyperactivity disorder (ADHD) and premature mortality: A narrative review of the literature
  2. A new approach to assessment for young children referred by education professionals for socio‐emotional, behavioural, and cognitive difficulties
  3. Clinical and Cognitive Mediators Underlying Subsequent Depression in Individuals With Attention-Deficit/Hyperactivity Disorder: A Developmental Approach
  4. Heterogeneity in the longitudinal course of depressive symptomatology in adults with a history of recurrent major depressive disorder
  5. Stratifying the risk of transition to adult-onset psychiatric disorders in adolescents with anxiety
  6. Association between childhood ADHD problems and premature mortality: identifying modifiable cardiovascular mechanisms in a UK population cohort
  7. Childhood ADHD and autism spectrum disorder difficulties: exploring the impact of copy number variants on young adult outcomes
  8. Co‐development of a digital animated video on attention deficit hyperactivity disorder with children and parents/carers
  9. Antecedents and outcomes of a later attention–deficit hyperactivity disorder (ADHD) diagnosis in females
  10. Using a Developmental Approach to Investigate Behavioral, Neurodevelopmental, and Depressive Irritability Types
  11. Editorial Perspective: Overdiagnosis of ADHD ? Here we go again
  12. Trends in annual and lifetime prevalence of child and adolescent mental health service use in the UK between 1991 and 2023: Welsh healthcare register linkage study
  13. Youth depression: An overview of genetic findings and the challenge of heterogeneity
  14. Early Manifestations of Neurodevelopmental Copy Number Variants in Children: A Population-Based Investigation
  15. Study Preregistration: Clinical and Cognitive Mediators Underlying Subsequent Depression in Individuals With Attention-Deficit/Hyperactivity Disorder: A Developmental Approach
  16. Investigating Irritability as a Potentially Causal Risk Pathway to Depression Using Two Genetically Informed Designs
  17. Child Mental Health Research in Low- and Middle-Income Countries: A Twin-Family Feasibility Study in Nigeria
  18. Investigating the Symptom Presentation of Depression in Children With ADHD
  19. Genome-wide association study of adolescent-onset depression
  20. Reflections on the manifestation of attention-deficit hyperactivity disorder in girls from young adults with lived experiences: a qualitative study
  21. Mapping phenotypic and genetic relationships among irritability, depression and ADHD in adolescence using network analysis
  22. Co-development of a digital animated video on ADHD with children and families/carers
  23. Measuring irritability across childhood, adolescence, and young adulthood: an investigation of measurement invariance by age, sex, and informant
  24. Exploring the mental health research priorities of parents with depression and their children
  25. Skills for adolescent WELLbeing (SWELL): protocol for a preventive effectiveness randomised controlled trial for young people at high-familial risk of depression with treatment optimisation for parents with depression at study entry comparing online gr...
  26. An item-level systematic review of the presentation of ADHD in females
  27. Professorships in child and adolescent psychiatry relative to a similarly sized medical specialty in the UK and Ireland: cross-sectional study
  28. Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
  29. Neurofeedback for Attention-Deficit/Hyperactivity Disorder
  30. Correction: Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  31. Long-term physical health conditions and youth anxiety and depression: Is there a causal link?
  32. Investigating the reasons behind a later or missed diagnosis of attention‐deficit/hyperactivity disorder in young people: A population cohort study
  33. The impact of published guidance on trends in the pharmacological management of depression in children and adolescents- a whole population e-cohort data linkage study in Wales, UK
  34. Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?
  35. Investigating the neurodevelopmental correlates of early adolescent-onset emotional problems
  36. Polygenic liabilities and treatment trajectories in early-onset depression: a Danish register-based study
  37. Testing maternal effects of vitamin-D and omega-3 levels on offspring neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study
  38. The unequal impacts of the COVID‐19 pandemic on young adults' mental health. Predictors of vulnerability and resilience using longitudinal birth cohort data in the UK
  39. Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update
  40. Sex differences in attention‐deficit hyperactivity disorder diagnosis and clinical care: a national study of population healthcare records in Wales
  41. Emotional problems across development: examining measurement invariance across childhood, adolescence and early adulthood
  42. Irritability in Youths: A Critical Integrative Review
  43. Peter McGuffin CBE (February 4, 1949–January 30, 2024)
  44. Childhood correlates and young adult outcomes of trajectories of emotional problems from childhood to adolescence
  45. Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: Evidence From Multiple Genetically Informed Designs
  46. Rare X-linked variants carry predominantly male risk in autism, Tourette syndrome, and ADHD
  47. Association between relative age at school and persistence of ADHD in prospective studies: an individual participant data meta-analysis
  48. Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems
  49. Irritability in Youth: A Critical Integrative Review
  50. Sex differences in ADHD diagnosis and clinical care: A national study of population healthcare records in Wales
  51. Young Adult ADHD Symptoms in the General Population and Neurocognitive Impairment
  52. Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention‐deficit/hyperactivity disorder – a systematic review and meta‐analysis
  53. Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts
  54. Corrigendum to “Characterising depression trajectories in young people at high familial risk of depression” [J. Affect. Disord. 337 (2023) 66–74 (15 September)]
  55. Characterising depression trajectories in young people at high familial risk of depression
  56. Can a nation-wide e-cohort of ADHD and ASD in childhood be established using Welsh routinely available datasets?
  57. Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  58. Stratifying early‐onset emotional disorders: using genetics to assess persistence in young people of European and South Asian ancestry
  59. Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study
  60. Cross-cohort change in parent-reported emotional problem trajectories across childhood and adolescence in the UK
  61. Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems
  62. Developmental manifestations of polygenic risk for bipolar disorder from infancy to middle childhood
  63. Co‐development of attention deficit hyperactivity disorder and autistic trait trajectories from childhood to early adulthood
  64. Following the children of depressed parents from childhood to adult life: A focus on mood and anxiety disorders
  65. Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents
  66. Validation of the Strengths and Difficulties Questionnaire (SDQ) emotional subscale in assessing depression and anxiety across development
  67. Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes
  68. An agenda for future research regarding the mental health of young people with care experience
  69. Author Correction: Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains
  70. Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders
  71. Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic
  72. DRAGON-Data: a platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts
  73. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains
  74. Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder
  75. ADHD and Autism Spectrum Disorder (ASD) in Childhood: establishing the feasibility and validity of a nation-wide e-cohort
  76. Latent bipolar depression – Authors' reply
  77. Investigating Direct and Indirect Genetic Effects in Attention-Deficit/Hyperactivity Disorder Using Parent-Offspring Trios
  78. Using genetic designs to identify likely causal environmental contributions to psychopathology
  79. Disentangling the influences of parental genetics on offspring's cognition, education, and psychopathology via genetic and phenotypic pathways
  80. Rare Maternally Inherited Coding Variants on Chromosome X Carry Predominantly Male Risk in Autism, Tourette Syndrome, and Attention-deficit/Hyperactivity Disorder
  81. Developing and validating a prediction model of adolescent major depressive disorder in the offspring of depressed parents
  82. Preschool development, temperament and genetic liability as early markers of childhood ADHD: A cohort study
  83. Practitioner Review: Attention‐deficit hyperactivity disorder and autism spectrum disorder – the importance of depression
  84. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia
  85. Depression in young people
  86. Longitudinally stable, brain‐based predictive models mediate the relationships between childhood cognition and socio‐demographic, psychological and genetic factors
  87. Early manifestations of genetic liability for ADHD, autism and schizophrenia at ages 18 and 24 months
  88. Motivation and Cognitive Abilities as Mediators Between Polygenic Scores and Psychopathology in Children
  89. Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders
  90. Understanding de novo onset of anxiety during COVID‐19: Pre‐pandemic socio‐emotional functioning in vulnerable children
  91. Investigating direct and indirect genetic effects in attention deficit hyperactivity disorder (ADHD) using parent-offspring trios
  92. Decline in attention-deficit hyperactivity disorder traits over the life course in the general population: trajectories across five population birth cohorts spanning ages 3 to 45 years
  93. Investigating the associations between irritability and hot and cool executive functioning in those with ADHD
  94. Collecting genetic samples and linked mental health data from adolescents in schools: protocol coproduction and a mixed-methods pilot of feasibility and acceptability
  95. DRAGON-Data: A platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts
  96. “Late-onset” ADHD symptoms in young adulthood: Is this ADHD?
  97. Sleep disturbances in ADHD: investigating the contribution of polygenic liability for ADHD and sleep-related phenotypes
  98. Early-Life Injuries and the Development of Attention-Deficit/Hyperactivity Disorder
  99. Genetics of Attention-Deficit Hyperactivity Disorder
  100. Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study of children and young people in Wales, UK
  101. The antecedents and outcomes of persistent and remitting adolescent depressive symptom trajectories: a longitudinal, population-based English study
  102. ADHD in adults with recurrent depression
  103. Validation of the short Mood and Feelings Questionnaire in young adulthood
  104. Assessment of age-at-onset criterion for adult attention-deficit hyperactivity disorder
  105. Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression
  106. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD
  107. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
  108. Variable Emergence of Autism Spectrum Disorder Symptoms From Childhood to Early Adulthood
  109. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
  110. The neurodiversity concept: is it helpful for clinicians and scientists?
  111. Exploring ADHD Symptoms and Associated Impairment across Development
  112. Is genetic liability to ADHD and ASD causally linked to educational attainment?
  113. Correction to: Examining the Role of Genetic Risk and Longitudinal Transmission Processes Underlying Maternal Parenting and Psychopathology and Children’s ADHD Symptoms and Aggression: Utilizing the Advantages of a Prospective Adoption Design
  114. ADHD and autism symptoms in youth: a network analysis
  115. Sex differences in anxiety and depression in children with attention deficit hyperactivity disorder: Investigating genetic liability and comorbidity
  116. Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: a GWAS meta-analysis
  117. Investigating Friendship Difficulties in the Pathway from ADHD to Depressive Symptoms. Can Parent–Child Relationships Compensate?
  118. Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression
  119. Longitudinally stable, brain-based predictive models mediate the relationships between childhood cognition and socio-demographic, psychological and genetic factors
  120. Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
  121. ADHD in adults with recurrent depression
  122. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood
  123. Validation of the short Mood and Feelings Questionnaire in young adulthood
  124. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
  125. What has happened to children's wellbeing in the UK?
  126. The Effect of Attention Deficit/Hyperactivity Disorder on Physical Health Outcomes: A 2-Sample Mendelian Randomization Study
  127. Development of ADHD: Etiology, Heterogeneity, and Early Life Course
  128. Collecting genetic samples and linked mental health data from adolescents in schools: Protocol co-production and a mixed-methods pilot of feasibility and acceptability
  129. Genetic Advances in Autism
  130. ADHD: Progressing From Genetic Discoveries to Biological Insights
  131. A Digital Intervention for Adolescent Depression (MoodHwb): Mixed Methods Feasibility Evaluation
  132. Investigating attention‐deficit hyperactivity disorder and autism spectrum disorder traits in the general population: What happens in adult life?
  133. Examining the Role of Genetic Risk and Longitudinal Transmission Processes Underlying Maternal Parenting and Psychopathology and Children’s ADHD Symptoms and Aggression: Utilizing the Advantages of a Prospective Adoption Design
  134. Pilot study to establish a prospective neonatal cohort: Study of Preterm Infants and Neurodevelopmental Genes (SPRING)
  135. Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals
  136. Motivation and Cognitive Abilities as Mediators between Polygenic Scores and Psychopathology in Children
  137. The ADHD paper that triggered a backlash, and what it taught me
  138. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder
  139. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank
  140. Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: A GWAS meta-analysis
  141. ADHD and depression: investigating a causal explanation
  142. Family-Based Designs that Disentangle Inherited Factors from Pre- and Postnatal Environmental Exposures: In Vitro Fertilization, Discordant Sibling Pairs, Maternal versus Paternal Comparisons, and Adoption Designs
  143. Contribution of de novo and inherited rare CNVs to very preterm birth
  144. Is genetic liability to ADHD and ASD causally linked to educational attainment?
  145. Using a cross-cohort comparison design to test the role of maternal smoking in pregnancy in child mental health and learning: evidence from two UK cohorts born four decades apart
  146. The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?
  147. What explains the link between childhood ADHD and adolescent depression? Investigating the role of peer relationships and academic attainment
  148. Infant Neuromotor Development: An Early Indicator of Genetic Liability for Neurodevelopmental Disorders
  149. Recent advances in the genetics of preterm birth
  150. Disentangling nature from nurture in examining the interplay between parent–child relationships, ADHD, and early academic attainment
  151. A brief report: de novo copy number variants in children with attention deficit hyperactivity disorder
  152. Using Genetics to Examine a General Liability to Childhood Psychopathology
  153. Genetic liability to ADHD and substance use disorders in individuals with ADHD
  154. Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Behavior
  155. A Digital Intervention for Adolescent Depression (MoodHwb): Mixed Methods Feasibility Evaluation (Preprint)
  156. Identifying Novel Types of Irritability Using a Developmental Genetic Approach
  157. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures
  158. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample - ERRATUM
  159. Adult mood problems in children with neurodevelopmental problems: evidence from a prospective birth cohort followed to age 50
  160. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample
  161. A cross-disorder MR-pheWAS of 5 major psychiatric disorders in UK Biobank
  162. ADHD genetic liability and physical health outcomes - A two-sample Mendelian randomization study
  163. Cross‐cohort change in adolescent outcomes for children with mental health problems
  164. Childhood neurodevelopmental difficulties and risk of adolescent depression: the role of irritability
  165. Irritability in ADHD: association with later depression symptoms
  166. Do natural experiments have an important future in the study of mental disorders?
  167. Adolescent and adult differences in major depression symptom profiles
  168. Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories
  169. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
  170. Advances in our understanding of the genetics of childhood neurodevelopmental disorders
  171. Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression
  172. Identifying novel subtypes of irritability using a developmental genetic approach
  173. Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications
  174. The contribution of psychiatric risk alleles to a general liability to psychopathology in early life
  175. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome
  176. Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy
  177. Facial Emotion Recognition and Eye Gaze in Attention-Deficit/Hyperactivity Disorder With and Without Comorbid Conduct Disorder
  178. Resilience in high-risk adolescents of mothers with recurrent depressive disorder: The contribution of fathers
  179. A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
  180. Psychoeducational interventions in adolescent depression: A systematic review
  181. Association of copy number variation across the genome with neuropsychiatric traits in the general population
  182. Investigating late-onset ADHD: a population cohort investigation
  183. Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population
  184. A Web-Based Psychoeducational Intervention for Adolescent Depression: Design and Development of MoodHwb
  185. The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age
  186. The presentation of depression symptoms in attention-deficit/hyperactivity disorder: comparing child and parent reports
  187. Oxytocin increases attention to the eyes and selectively enhances self-reported affective empathy for fear
  188. A Web-Based Psychoeducational Intervention for Adolescent Depression: Design and Development of MoodHwb (Preprint)
  189. The WPA- Lancet Psychiatry Commission on the Future of Psychiatry
  190. Investigating the genetic underpinnings of early-life irritability
  191. Parent Psychopathology and Neurocognitive Functioning in Children With ADHD
  192. A genetic investigation of sex bias in the prevalence of attention deficit hyperactivity disorder
  193. Discovery Of The First Genome-Wide Significant Risk Loci For ADHD
  194. Irritability in ADHD: Associations with depression liability
  195. Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development
  196. Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment—Reply
  197. Neurodevelopmental disorders
  198. Antecedents of New-Onset Major Depressive Disorder in Children and Adolescents at High Familial Risk
  199. Intellectual Disability and Attention-Deficit/Hyperactivity Disorder: What Does the Clinical and Genetic Overlap Mean for Practice and Research?
  200. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study
  201. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population
  202. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood
  203. Prevalence and correlates of psychotic experiences amongst children of depressed parents
  204. Identifying key parent-reported symptoms for detecting depression in high risk adolescents
  205. Cortisol levels at baseline and under stress in adolescent males with attention-deficit hyperactivity disorder, with or without comorbid conduct disorder
  206. Do better executive functions buffer the effect of current parental depression on adolescent depressive symptoms?
  207. Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study
  208. Pathway analysis in attention deficit hyperactivity disorder: An ensemble approach
  209. Attention deficit hyperactivity disorder
  210. Examining whether offspring psychopathology influences illness course in mothers with recurrent depression using a high-risk longitudinal sample.
  211. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study
  212. In Reply
  213. Profiling depression in childhood and adolescence: the role of conduct problems
  214. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome
  215. Identifying mechanisms that underlie links betweenCOMTgenotype and aggression in male adolescents with ADHD
  216. Emotion Regulation in Adolescent Males with Attention-Deficit Hyperactivity Disorder: Testing the Effects of Comorbid Conduct Disorder
  217. Correction: Association between Maternal Depression Symptoms across the First Eleven Years of Their Child's Life and Subsequent Offspring Suicidal Ideation
  218. Longitudinal symptom course in adults with recurrent depression: Impact on impairment and risk of psychopathology in offspring
  219. Pain Sensitivity in Adolescent Males with Attention-Deficit/Hyperactivity Disorder: Testing for Associations with Conduct Disorder and Callous and Unemotional Traits
  220. Association between Maternal Depression Symptoms across the First Eleven Years of Their Child’s Life and Subsequent Offspring Suicidal Ideation
  221. Parents and Genes and Their Effects on Alcohol, Drugs, and Crime in Triparental Families
  222. Pathways to Suicide-Related Behavior in Offspring of Mothers With Depression: The Role of Offspring Psychopathology
  223. Shared Genetic Influences Between Attention-Deficit/Hyperactivity Disorder (ADHD) Traits in Children and Clinical ADHD
  224. Affective bias and current, past and future adolescent depression: A familial high risk study
  225. Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
  226. The relative contribution of common and rare genetic variants to ADHD
  227. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
  228. ADHD severity is associated with white matter microstructure in the subgenual cingulum
  229. Maternal caregiving and girls' depressive symptom and antisocial behavior trajectories: An examination among high-risk youth
  230. Neurocognitive abilities in the general population and composite genetic risk scores for attention-deficit hyperactivity disorder
  231. Genetic Risk for Attention-Deficit/Hyperactivity Disorder Contributes to Neurodevelopmental Traits in the General Population
  232. Editorial Perspective: Why is there such a mismatch between traditional heritability estimates and molecular genetic findings for behavioural traits?
  233. Biological Overlap of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: Evidence From Copy Number Variants
  234. Trends in parent- and teacher-rated emotional, conduct and ADHD problems and their impact in prepubertal children in Great Britain: 1999-2008
  235. A longitudinal high‐risk study of adolescent anxiety, depression and parent‐severity on the developmental course of risk‐adjustment
  236. Reported child awareness of parental depression
  237. White Matter Microstructure Predicts Autistic Traits in Attention-Deficit/Hyperactivity Disorder
  238. Genetic variation associated with euphorigenic effects of d -amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder
  239. Antenatal Acetaminophen Use and Attention-Deficit/Hyperactivity Disorder
  240. Common adolescent mental disorders: transition to adulthood
  241. Validation of a composite of suicide items from the Mood and Feelings Questionnaire (MFQ) in offspring of recurrently depressed parents
  242. Precursors to aggression are evident by 6 months of age
  243. Genetic Associations Between the Symptoms of Attention-Deficit/Hyperactivity Disorder and Emotional Lability in Child and Adolescent Twins
  244. Commentary: Maternal pre-pregnancy BMI and offspring ADHD: a lesson in the importance of testing causal pathways
  245. Psychopathology and cognition in children with 22q11.2 deletion syndrome
  246. Detecting recurrent major depressive disorder within primary care rapidly and reliably using short questionnaire measures
  247. The Depression Impairment Scale for Parents (DISP): A new scale for the measurement of impairment in depressed parents
  248. Specific Parental Depression Symptoms as Risk Markers for New-Onset Depression in High-Risk Offspring
  249. Biological and rearing mother influences on child ADHD symptoms: revisiting the developmental interface between nature and nurture
  250. Intellectual Disability in Children with Attention Deficit Hyperactivity Disorder
  251. Depression and blood pressure in high-risk children and adolescents: an investigation using two longitudinal cohorts
  252. Parent–child hostility and child and adolescent depression symptoms: the direction of effects, role of genetic factors and gender
  253. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
  254. Copy Number Variation: What Is It and What Has It Told Us About Child Psychiatric Disorders?
  255. High Loading of Polygenic Risk for ADHD in Children With Comorbid Aggression
  256. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia
  257. The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS)
  258. Association between obesity and depressive disorder in adolescents at high risk for depression
  259. Maternal depression and co-occurring antisocial behaviour: testing maternal hostility and warmth as mediators of risk for offspring psychopathology
  260. Factor Structure of Autistic Traits in Children with ADHD
  261. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome-wide association study of both common and rare variants
  262. A Direct Method of Assessing Underlying Cognitive Risk for Adolescent Depression
  263. Autistic traits in children with ADHD index clinical and cognitive problems
  264. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
  265. Are parental ADHD problems associated with a more severe clinical presentation and greater family adversity in children with ADHD?
  266. Examining the role of passive gene–environment correlation in childhood depression using a novel genetically sensitive design
  267. The nature of nurture: Disentangling passive genotype–environment correlation from family relationship influences on children's externalizing problems.
  268. Do parents know best? Parent-reported vs. child-reported depression symptoms as predictors of future child mood disorder in a high-risk sample
  269. The ADHD debate: being mindful of complexity and wary of reductionist explanations and polarization
  270. Shared biological risks that influence brain and behaviour
  271. Interparental conflict, parent psychopathology, hostile parenting, and child antisocial behavior: Examining the role of maternal versus paternal influences using a novel genetically sensitive research design
  272. Risk of psychopathology in adolescent offspring of mothers with psychopathology and recurrent depression
  273. Practitioner Review: What have we learnt about the causes of ADHD?
  274. Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence
  275. Maternal and Paternal Smoking During Pregnancy and Risk of ADHD Symptoms in Offspring: Testing for Intrauterine Effects
  276. Missed opportunities: mental disorder in children of parents with depression
  277. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder
  278. ‘The risks of playing it safe’: a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents
  279. Review: psychological and educational interventions may reduce risk of depressive disorders in children and adolescents
  280. Depression in adolescence
  281. The association between early autistic traits and psychotic experiences in adolescence
  282. Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3
  283. Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD
  284. Offspring of parents with recurrent depression: Which features of parent depression index risk for offspring psychopathology?
  285. Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants
  286. Using a genetically informative design to examine the relationship between breastfeeding and childhood conduct problems
  287. Genome-wide association study in German patients with attention deficit/hyperactivity disorder
  288. What causes attention deficit hyperactivity disorder?
  289. Known Risk Factors for Violence Predict 12-Month-Old Infants’ Aggressiveness With Peers
  290. Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy
  291. Maternal Depression and Child and Adolescent Depression Symptoms: An Exploratory Test for Moderation by CRHR1, FKBP5 and NR3C1 Gene Variants
  292. Investigating Environmental Links Between Parent Depression and Child Depressive/Anxiety Symptoms Using an Assisted Conception Design
  293. Neurodevelopmental hypothesis of schizophrenia
  294. Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder
  295. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder
  296. Genotype Link With Extreme Antisocial Behavior
  297. Identifying early signs of aggression: psychometric properties of the cardiff infant contentiousness scale
  298. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis
  299. Familial transmission of depression and antisocial behavior symptoms: disentangling the contribution of inherited and environmental factors and testing the mediating role of parenting
  300. Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder
  301. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder
  302. Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD)
  303. Estimating the relative contributions of maternal genetic, paternal genetic and intrauterine factors to offspring birth weight and head circumference
  304. Bipolar spectrum disorders in primary care: optimising diagnosis and treatment
  305. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder
  306. Managing and preventing depression in adolescents
  307. Gene-Environment Interactions
  308. Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity
  309. Should We Be Rethinking How We Assess and Manage ADHD?
  310. Prenatal Smoking Might Not Cause Attention-Deficit/Hyperactivity Disorder: Evidence from a Novel Design
  311. Dissecting the phenotype in genome-wide association studies of psychiatric illness
  312. Do prenatal risk factors cause psychiatric disorder? Be wary of causal claims
  313. Parent-child hostility and child ADHD symptoms: a genetically sensitive and longitudinal analysis
  314. Associations between maternal older age, family environment and parent and child wellbeing in families using assisted reproductive techniques to conceive
  315. The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences
  316. Genomewide Association Studies: History, Rationale, and Prospects for Psychiatric Disorders
  317. Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology
  318. An Overview on the Genetics of ADHD
  319. Disentangling prenatal and inherited influences in humans with an experimental design
  320. NK1 (TACR1) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD
  321. Psychopathy traits in adolescents with childhood attention-deficit hyperactivity disorder
  322. Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures
  323. Genetic influences on the development of childhood psychiatric disorders
  324. Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder
  325. A Replicated Molecular Genetic Basis for Subtyping Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder
  326. Psychopathology in children and adolescents with epilepsy: An investigation of predictive variables
  327. Parent–Child Relationships and ADHD Symptoms: A Longitudinal Analysis
  328. Mental Health and Functional Outcomes of Maternal and Adolescent Reports of Adolescent Depressive Symptoms
  329. Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: The influence of maternal and child characteristics
  330. Do intrauterine or genetic influences explain the foetal origins of chronic disease? A novel experimental method for disentangling effects
  331. Effects of low birth weight, maternal smoking in pregnancy and social class on the phenotypic manifestation of Attention Deficit Hyperactivity Disorder and associated antisocial behaviour: investigation in a clinical sample
  332. Genetic and environmental influences on the relationship between peer alcohol use and own alcohol use in adolescents
  333. Advances in genetic findings on attention deficit hyperactivity disorder
  334. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use
  335. The impact of gestational stress and prenatal growth on emotional problems in offspring: a review
  336. Clinical Precursors of Adolescent Conduct Disorder in Children With Attention-Deficit/Hyperactivity Disorder
  337. The Cardiff Study of All Wales and North West of England Twins (CaStANET): A Longitudinal Research Program of Child and Adolescent Development
  338. Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth
  339. Testing for gene × environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior
  340. Gene–environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective
  341. The Association between Conduct Problems and the Initiation and Progression of Marijuana Use during Adolescence: A Genetic Analysis across Time
  342. Phenotypic variation between parent–offspring trios and non-trios in genetic studies of schizophrenia
  343. Twin Studies in Pediatric Depression
  344. Relationship between disabling fatigue and depression in children
  345. Family Conflict Interacts With Genetic Liability in Predicting Childhood and Adolescent Depression
  346. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies
  347. The effect of birth-weight with genetic susceptibility on depressive symptoms in childhood and adolescence
  348. Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder
  349. Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder
  350. Do depression symptoms predict seizure frequency—or vice versa?
  351. The genetics of attention deficit hyperactivity disorder
  352. Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene
  353. The Link between Depression in Mothers and Offspring: An Extended Twin Analysis
  354. The definition of disabling fatigue in children and adolescents
  355. Relationship between antisocial behaviour, attention-deficit hyperactivity disorder and maternal prenatal smoking
  356. Twins Born Following Fertility Treatment: Implications for Quantitative Genetic Studies
  357. A Family Based Study Implicates Solute Carrier Family 1–Member 3 (SLC1A3) Gene in Attention-Deficit/Hyperactivity Disorder
  358. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD
  359. Characterizing the ADHD phenotype for genetic studies
  360. No support for association between the dopamine transporter (DAT1) gene and ADHD
  361. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD)
  362. A population-based study of anxiety as a precursor for depression in childhood and adolescence
  363. No evidence of association between Catechol-O-Methyltransferase (COMT) Val 158 Met genotype and performance on neuropsychological tasks in children with ADHD: A case-control study
  364. Prevalence of chronic disabling fatigue in children and adolescents
  365. Joint Analysis of the DRD5 Marker Concludes Association with Attention-Deficit/Hyperactivity Disorder Confined to the Predominantly Inattentive and Combined Subtypes
  366. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD
  367. Direct analysis of the genes encoding G proteins G?T2, G?o, G?Z in ADHD
  368. Association of the Dopamine D4Receptor Gene 7-Repeat Allele With Neuropsychological Test Performance of Children With ADHD
  369. The Child Attention-Deficit Hyperactivity Disorder Teacher Telephone Interview (CHATTI): reliability and validity
  370. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis
  371. Maternal Smoking During Pregnancy and Attention Deficit Hyperactivity Disorder Symptoms in Offspring
  372. Depressive symptoms in children and adolescents: changing aetiological influences with development
  373. Negative life events as an account of age-related differences in the genetic aetiology of depression in childhood and adolescence
  374. No evidence of association between HLA-DRB1 and attention deficit hyperactivity disorder
  375. Association between PRODH and schizophrenia is not confirmed
  376. Association analysis of monoamine oxidase a and attention deficit hyperactivity disorder
  377. Assessing the effects of age, sex and shared environment on the genetic aetiology of depression in childhood and adolescence
  378. Evidence to suggest biased phenotypes in children with Attention Deficit Hyperactivity Disorder from completely ascertained trios
  379. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample
  380. Is primary care ready to take on Attention Deficit Hyperactivity Disorder?
  381. Association of DRD4 in children with ADHD and comorbid conduct problems
  382. The genetic aetiology of childhood depression: a review
  383. No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder
  384. Susceptibility genes for a trait measure of attention deficit hyperactivity disorder: a pilot study in a non-clinical sample of twins
  385. Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design
  386. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study
  387. Does the Definition of ADHD Affect Heritability?
  388. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
  389. Genetic basis of attention deficit and hyperactivity
  390. Life Events and Depressive Symptoms in Childhood — Shared Genes or Shared Adversity? A Research Note
  391. Validity of the shortened Mood and Feelings Questionnaire in a community sample of children and adolescents: a preliminary research note
  392. Attention deficit hyperactivity disorder: unravelling the molecular genetics
  393. Genes and social skills
  394. Attitudes of general practitioners towards health care for people with intellectual disability and the factors underlying these attitudes
  395. Anxiety and Depressive Symptoms in Childhood?A Genetic Study of Comorbidity
  396. Genetic basis of bad behaviour in adolescents
  397. Childhood hyperactivity scores are highly heritable and show sibling competition effects: Twin study evidence
  398. Are Anxiety Symptoms in Childhood Heritable?
  399. A Twin Study of Depressive Symptoms in Childhood
  400. The Genetics of Mental Retardation
  401. The Genetics of Personality Disorder